Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Saving Vaccines: A Look at How Current Liability Laws Are Keeping Much-Needed Vaccines Off the Market
On April 12, 1955, Thomas Francis stood on a podium at the University of Michigan and announced that Jonas Salk's polio vaccine was safe and effective. At last, Americans would be freed from the bonds of polio, a disease that routinely crippled as many as 50,000 children every year. However, triumph quickly turned to tragedy.
On April 28, 1955, 2 weeks after millions of doses of Salk's formaldehyde-inactivated polio vaccine had been sold to the public, several children developed paralysis. All of the paralyzed children lived in the West and Southwest; all first developed paralysis in the arm that was injected and, although five companies made polio vaccine in 1955, all had received vaccine made by one company ' Cutter Laboratories of Berkeley, CA.
The federal agency responsible for licensing vaccines in 1955, the Laboratory of Biologics Control, asked Cutter to recall all of its vaccine. Unfortunately, it was too late; 120,000 children had already been injected with a vaccine that inadvertently contained live, dangerous polio virus. As a consequence, 40,000 children developed mild polio; 200 were permanently paralyzed, and 10 were killed. It was one of the worst pharmaceutical disasters in U.S. history.
This premium content is locked for Entertainment Law & Finance subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Major Differences In UK, U.S. Copyright Laws
This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
The Article 8 Opt In
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
Strategy vs. Tactics: Two Sides of a Difficult Coin
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
Legal Possession: What Does It Mean?
Possession of real property is a matter of physical fact. Having the right or legal entitlement to possession is not "possession," possession is "the fact of having or holding property in one's power." That power means having physical dominion and control over the property.
The Anti-Assignment Override Provisions
UCC Sections 9406(d) and 9408(a) are one of the most powerful, yet least understood, sections of the Uniform Commercial Code. On their face, they appear to override anti-assignment provisions in agreements that would limit the grant of a security interest. But do these sections really work?